HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAsafety guidance66% confidence

Convenience Kit Correction: Arrow International Issues Correction for Convenience Kits Containing Recalled Huons Lidocaine and Bupivacaine and Saline

Source: FDA

Why This Matters

Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Merck; the same agency is already in play for this signal, so precedent weight is higher.

Regulatory Analysis

Saline, Lidocaine and Bupivacaine from affected convenience kits should not be used.

Supporting Context

Therapeutic area
Infectious Disease · HIV
Sub-indication
General

Related signal: FDA Accepts NDA for IDVYNSO Containing Doravirine and Islatravir

Source

View source document

Related Signal

Open signal — FDA Accepts NDA for IDVYNSO Containing Doravirine and Islatravir
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.